Clopidogrel Bisulphate USP represents a premium-grade active pharmaceutical ingredient specifically engineered for antiplatelet therapy applications. This high-purity compound, wit...

Clopidogrel Bisulphate USP represents a premium-grade active pharmaceutical ingredient specifically engineered for antiplatelet therapy applications. This high-purity compound, with chemical formula C15H16ClNO6S2 and molecular weight 405.87, strictly complies with United States Pharmacopeia standards, ensuring pharmaceutical manufacturers receive consistent quality and reliability. Sourced from certified facilities in Maharashtra, India, our Clopidogrel Bisulphate undergoes comprehensive testing protocols to guarantee purity, potency, and batch-to-batch consistency. As the foundational component in medications that prevent dangerous blood clot formation, this API plays a crucial role in modern cardiovascular treatment protocols. Its exceptional chemical stability and compatibility with various pharmaceutical excipients make it ideally suited for tablet formulations and other oral dosage forms.

This antiplatelet API serves pharmaceutical companies specializing in cardiovascular medications, including both generic and branded drug manufacturers. The cardiology sector represents the primary application area, with medications containing Clopidogrel Bisulphate being prescribed for acute coronary syndrome, recent myocardial infarction, ischemic strokes, and established peripheral arterial disease. Hospital pharmacies, large-scale production facilities, and contract manufacturing organizations incorporate this API into their manufacturing processes to create essential medications. Pharmaceutical exporters and distributors depend on the consistent quality when supplying international markets where cardiovascular disease prevalence demands reliable antiplatelet treatments that meet rigorous regulatory standards.

Manufacturers selecting our Clopidogrel Bisulphate USP benefit from exceptional reliability and supply chain consistency that supports uninterrupted production schedules. Our product distinguishes itself through rigorous quality control measures that ensure every batch meets exacting pharmaceutical standards, providing peace of mind for drug manufacturers. The API's compliance with global pharmacopeia standards significantly reduces regulatory challenges and streamlines the drug approval process for our clients. This manufacturing reliability translates directly to reduced production interruptions, consistent final product quality, and enhanced patient safety for the medications utilizing this critical antiplatelet ingredient.

Key Features:
- Complies with United States Pharmacopeia (USP) quality standards
- Chemical formula C15H16ClNO6S2 with molecular weight 405.87
- Sourced from certified manufacturing facilities in Maharashtra, India
- Medicine grade purity suitable for pharmaceutical formulations
- Rigorous testing protocols ensure batch-to-batch consistency

Benefits:
- Ensures regulatory compliance and simplifies drug approval processes
- Provides consistent antiplatelet efficacy in final pharmaceutical products
- Supports reliable manufacturing with minimal production interruptions
- Enhances patient safety through high-purity ingredient quality
- Maintains chemical stability throughout shelf life and manufacturing